Fitzgerald Health Education Associates

December 2014

Fitzgerald Health Education Associates (FHEA) is committed to the success of nurse practitioners; we publish practical information for practicing NPs and NP students, which includes NP interviews, NP certification Q&A;, avoiding malpractice, and news.

Issue link: https://fhea.epubxp.com/i/439772

Contents of this Issue

Navigation

Page 5 of 25

5 Fitzgerald Health Education Associates, Inc., December 2014 fhea.com I n an elderly patient who is treatment naïve, selec- tive serotonin reuptake inhibitors (SSRIs) are pre- ferred as the initial treatment agent because of their low side-effect profile and generally positive safety profile. 1,2 Either sertraline (Zoloft) or escitalopram (Lexapro) are the preferred SSRI medications in this age-group, largely because other SSRIs and other classes of anti- depressants are associated with greater risk of drug- drug interactions and adverse events in older adults. For example, fluoxetine (Prozac) and paroxetine (Paxil) are both CYP450 2D6 inhibitors and thus can in- crease serum levels of some beta-blockers and statins, medications often used concomitantly in older adults. Both fluoxetine and paroxetine can also increase bleeding risk when used with warfarin and non - steroid al anti-inflammatory drugs (NSAIDs). Citalopram (Celexa), once a favorite SSRI for use in older adults, is now seldom used because of its potential for causing prolonged QT interval and torsade de pointes. 3 If citalopram is prescribed, the maximum dose in pa- tients 60 years of age or older is 20 mg/d. Patients tak- ing citalopram should undergo routine ECG. 1,2 In the elderly patient who is having difficulty sleeping and can benefit from weight gain, mirtaza - pine (Remeron) can be an appropriate first-line med- ication. Mirtazapine increases norepinephrine and serotonin neurotransmission in a manner different from SSRIs. It is classified as an alpha-2 adrenoceptor antagonist (ie, noradrenergic and specific serotoner- gic antidepressant, or NaSSA). Mirtazapine blocks his- tamine receptors, which accounts for its side effects of drowsiness and weight gain. 2 Careful Dosing and Monitoring Are Key With the elderly, the adage "start slow, go low" is important to remember. Elderly patients typically require a lower oral dose than younger patients to reach a particular blood level, and they tolerate a given blood level less well than younger patients. 2 However, this doesn't mean that you must prescribe at a low dose only. 2,4 Blood levels at which antidepressant medications are maximally effective for elderly patients appear to be the same as those for younger patients. 2 Practitioners should start with as low a dose as possible and continue to monitor the medication's effects on depression symptoms, increasing the dosage of the medication slowly as tolerated, and only if necessary to achieve remission of symptoms. Using a free, online measurement- based tool, such as the Patient Health Questionnaire (PHQ-9) , is recommended to monitor response to medications over time. 2 Dose regimens should be adjusted for age-related metabolic changes, paying close attention to hepatic and renal metabolic function. 2 For patients who are also taking other medications, careful attention must be paid to potential drug interactions. 2 Psychiatric Consult Which Medication Is Best for an Older Adult with Depression? Tess Judge-Ellis, DNP, ARNP, FAANP Continued on page 7

Articles in this issue

Links on this page

Archives of this issue

view archives of Fitzgerald Health Education Associates - December 2014